Medical decision making in antipsychotic drug choice for schizophrenia.
The influence of patient and physician variables on antipsychotic drug choice for patients with schizophrenia was assessed. Interviews with 100 psychiatrists on drug choice for 200 patients suffering from schizophrenia were conducted. Data were analyzed by using multiple logistic regression. Older physicians were up to five times more likely to prescribe first-generation antipsychotics. Patient variables did not influence treatment decisions significantly. There is an urgent need for more research on clinical decision making and quality management.